Navigation Links
Texcel Highlights Medical Device Development & Manufacturing Solutions at MD&M West, booth 314
Date:2/4/2009

EAST LONGMEADOW, Mass., Feb. 4 /PRNewswire/ -- Texcel's custom medical device development and manufacturing solutions helps companies around the world accelerate the commercialization of their surgical, interventional, and implantable medical device technologies. Texcel will highlight its full array of services and technologies at the MD&M West Expo, February 10-12, 2009, in exposition booth # 314.

Texcel provides the manufacturing infrastructure and expertise for a wide range of product applications -- from endoscopic surgical instrumentation and spinal/orthopedic implants to total artificial hearts and neurostimulators.

Texcel's specialized services and full medical device solutions include device design, development history file management, quality and regulatory assistance, process validation, along with general manufacturing, electronic testing, laser welding, and clean-room processing for a wide range of product applications.

Texcel, with more than 20 years of experience assisting companies execute increasingly sophisticated designs through reliable manufacturing, has particular expertise in five key areas:

  • Orthopedics, including products ranging from metal bone fastening devices to novel new materials;
  • Cardiac Assist, with expertise helping industry pioneers assemble and produce many types of cardiac assist devices;
  • Active Implantables, including a wide range of metal and non-metal biocompatible materials as well
    '/>"/>

SOURCE Texcel
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
2. Highlights of Economic and Business Growth in the Tampa Bay Region
3. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
4. Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights
5. Highlights of Economic and Business Growth in the Tampa Bay Region
6. Highlights of Economic and Business Growth in the Tampa Bay Region
7. Oncothyreon highlights corporate and clinical objectives for 2008
8. CyberKnife Users Meeting Highlights Major Clinical Data Milestones and Emerging Trends
9. National Nanotechnology Initiative releases its fiscal year 2009 budget and highlights
10. MEDEA+ Noblanc award highlights improvements in microelectronics
11. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...wire-Asia/ -- The world is going through,extraordi... is part of many,businesses and industries. It tur...y immune to the economic downturn, because illness...dst of the difficult times this year, the pharmace...R&D center in Shanghai, the largest of,its kin...
(Date:12/1/2009)... announced that he has joined Carolina Eyecare Phy... www.DrKerrySolomon.com , which was developed by ... LASIK, lens implant, and cataract surgery expert ...stantial contributions to improving vision correct...eons, which screens LASIK surgeons based upon expe...
(Date:12/1/2009)...ire/ -- Reportlinker.com announces that a new mark...,, Industrial Enzymes - A Global Market Report...strial-Enzymes---A-Global-Market-Report.html ,...ew strong players and a host of small suppliers en... and commoditization characterize the industry. Ra...
(Date:12/1/2009)... To address the emergence of the s...tial, a group of individuals and companies announc... Association (SynBIA) in Cambridge, Massachusetts ...de a forum for individuals and commercial interest...nities and its challenges, and advocate for its de...
Breaking Biology Technology:Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2
...on Andy, Holder Completes First Year Inspiring Oth... Conditions, VALLEY FORGE, Pa., Jan. 17 In 2007...ppe(R), teamed up with "Iron Andy" Holder,as part ...campaign. Andy,set out to speak about living with ... resonated with dozens of individuals who were ins...
...ISON, N.J., Jan. 17 Wyeth Consumer Healthcare, a,...U.S. Food and Drug,Administration,s (FDA) decision...ugh and cold products in children under age two., ...emoval in October 2007,of over-the-counter infant ...help reduce dosing errors and overdoses in childre...
...or Advancement Towards Creating Patient-Specific a... For Therapeutic Use, LA JOLLA, Calif., Jan. 17 ...earch company, announced today it has become the,f...ment, a cloned human,embryo using somatic cell nuc...d, M.D., Ph.D., a co-author of the,publication and...
Other Biology Technology:Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits 2Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits 3Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age 2Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age 3Stemagen First to Create Cloned Human Embryos From Adult Cells 2Stemagen First to Create Cloned Human Embryos From Adult Cells 3
(Date:12/1/2009)...r 1, 2009: OptiNose is pleased to announce the pub...dy investigating the efficacy and tolerability of ...topical treatment of chronic rhinosinusitis with n...f the International and European Rhinologic Societ... is a chronic disease that can significantly reduc...
(Date:12/1/2009)...eorgia Institute of Technology has been awarded a ...structures for energy harvesting and adaptive mate...ognitive processes of the modern warfighter. , ...abled Inorganic/Organic Nanostructures and Improve...mir Tsukruk and Kenneth Sandhage, professors in Ge...
(Date:12/1/2009)...rld first, a Monash University-led international r...ost the output of the next generation of solar cel...oration with colleagues from the universities of W... dye-sensitised solar cells with a three-fold incr... previously reported tandem dye-sensitised solar c...
Breaking Biology News(10 mins):New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4Innovation puts next-generation solar cells on the horizon 2Journal of Midwifery 26amp 3B Womens Health honors outstanding authors 54619 1Journal of Midwifery 26amp 3B Womens Health honors outstanding authors 54619 2Imagenetix Inc Announces Interview With Bloomberg Radio 13589 1Imagenetix Inc Announces Interview With Bloomberg Radio 13589 2Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 1Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 2Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 3Real World Study Showed Cost Savings for VTE Prophylaxis with Enoxaparin Compared with Unfractionated Heparin 28UFH 29 4856 4
..., Ohio (April 21, 2008) The technique lizards use...rding to researchers at Ohio University. , A res...acked 18 different species of lizards as they walk...g styles impact their biomechanics. The study, fun...ed in the April 1 edition of the Journal of Experi...
...urg, Va. Researchers from the Virginia Bioinforma...lleagues have identified a key function of a large...nt role in the production of infectious disease by...ofessor Brett Tyler and members of his research gr...partment of Plant Pathology, Physiology and Weed S...
...E #1 FOR IMMEDIATE RELEASE , Gel-like material... Biomacromolecules , Researchers in Texas report...p speed the long-awaited arrival of insulin that c...njections. The study is scheduled for the April 14.... , In the report, Nicholas A. Peppas and colleag...
Other Biology News:Lizard hunting styles impact ability to walk, run 2American Chemical Society's Weekly PressPac -- April 16, 2008 2American Chemical Society's Weekly PressPac -- April 16, 2008 3American Chemical Society's Weekly PressPac -- April 16, 2008 4American Chemical Society's Weekly PressPac -- April 16, 2008 5American Chemical Society's Weekly PressPac -- April 16, 2008 6American Chemical Society's Weekly PressPac -- April 16, 2008 7American Chemical Society's Weekly PressPac -- April 16, 2008 8
BLOCK-iT Adenoviral RNAi Expression System from Invitrogen
Mouse Anti-NFAT2 Monoclonal Antibody, Unconjugated, Clone 7A6 from Abcam
GIBCO Collagenase Type III from Invitrogen
Rabbit Anti-ETR3 Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: